Synergistic Brain Energy Support Systems

Publication ID: 24-11857527_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Brain Energy Support Systems,” Published Technical Disclosure No. 24-11857527_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857527_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,527.

Summary of the Inventive Concept

The present invention relates to novel systems and methods that combine medium chain triglyceride compositions with advanced technologies such as AI, IoT, blockchain, and new materials to create more effective and personalized treatments for brain energy deficiency conditions and neurological disorders.

Background and Problem Solved

The original patent disclosed the use of medium chain triglyceride compositions for treating brain energy deficiency conditions and neurological disorders. However, these compositions have limitations in terms of personalized dosage, real-time monitoring, and secure supply chain management. The present invention addresses these limitations by integrating the original composition with advanced technologies to create a more powerful and efficient system.

Detailed Description of the Inventive Concept

The inventive concept comprises a medium chain triglyceride composition, which is administered to a subject in need of brain energy support. The composition is combined with one or more advanced technologies, such as AI-powered algorithms for personalized dosage recommendations, wearable devices for real-time monitoring of brain activity, blockchain-secured supply chain management, IoT-enabled data transmission modules, and novel delivery systems using graphene-based materials. The system provides a synergistic effect, enhancing the efficacy and safety of the treatment. For example, the AI-powered algorithm can analyze the subject's genomic data and brain activity to provide personalized dosage recommendations, while the blockchain-secured supply chain ensures the authenticity and quality of the composition.

Novelty and Inventive Step

The inventive concept is novel and non-obvious in that it combines the original medium chain triglyceride composition with advanced technologies to create a more powerful and efficient system for brain energy support. The integration of these technologies provides a synergistic effect, enhancing the efficacy and safety of the treatment. The inventive concept is not obvious from the original patent, as it requires a deep understanding of the interplay between the composition and the advanced technologies.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept include the use of different AI algorithms, wearable devices, or blockchain platforms. Variations of the inventive concept include the use of different medium chain triglyceride compositions, novel delivery systems, or additional advanced technologies such as transcranial magnetic stimulation or neural interfaces.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare and nutrition industries, particularly in the areas of brain health and cognitive function. The market for brain health supplements is growing rapidly, and the inventive concept is well-positioned to capture a significant share of this market. Additionally, the inventive concept has potential applications in the pharmaceutical industry, particularly in the development of new treatments for neurological disorders.

Original Patent Information

Patent NumberUS 11,857,527
TitleMedium chain triglyceride compositions
Assignee(s)SOCIÉTÉ DES PRODUITS NESTLÉ S.A.